But now it appears that Miller never left the FDA. She’s still at the regulatory agency and has since been given a new—perhaps more prestigious—title. And as before, she is causing problems for the agency.
Miller is now the senior advisor to the chief of staff at the FDA. As an FDA employee, she has publicly promoted an unapproved drug as being “like a cure” for COVID-19 on Twitter. Her tweets support unproven and potentially dangerous statements from President Trump and may violate FDA regulations. The drug she promoted is currently being reviewed by the FDA for emergency use, raising concerns about the agency’s impartiality.
Though Miller’s Twitter account has been altered in recent days to remove her title at the FDA and any connection to the agency, she is still listed on the FDA’s website. The website does not list her new or old title, however.